Methylphenidate hydrochloride and Cardio-respiratory arrest - a phase IV clinical study of FDA data

Summary:

Cardio-respiratory arrest is reported as a side effect among people who take Methylphenidate hydrochloride (methylphenidate hydrochloride), especially for people who are male, 30-39 old, have been taking the drug for 1 - 6 months also take Pregabalin, and have Generalized anxiety disorder.

The phase IV clinical study analyzes which people have Cardio-respiratory arrest when taking Methylphenidate hydrochloride. It is created by eHealthMe based on reports of 6,364 people who have side effects when taking Methylphenidate hydrochloride from the FDA, and is updated regularly.

What is Methylphenidate hydrochloride?

Methylphenidate hydrochloride has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 6,822 Methylphenidate hydrochloride users. Check the latest studies of Methylphenidate hydrochloride.

What is Cardio-respiratory arrest?

Cardio-respiratory arrest (sudden dysfunction of heart and lungs) is found to be associated with 1,647 drugs and 1,767 conditions by eHealthMe. Check the latest studies of Cardio-respiratory arrest.

On Jul, 11, 2026

6,364 people reported to have side effects when taking Methylphenidate hydrochloride.
Among them, 57 people (0.9%) have Cardio-respiratory arrest.

Could Methylphenidate hydrochloride cause Cardio-respiratory arrest?

Among these 57 people:

How long have people been on Methylphenidate hydrochloride when they have Cardio-respiratory arrest? *

What is the gender of people who have Cardio-respiratory arrest when taking Methylphenidate hydrochloride? *

female: 10.91 %
male: 89.09 %

What is the age of people who have Cardio-respiratory arrest when taking Methylphenidate hydrochloride? *

What are other drugs people take besides Methylphenidate hydrochloride? *

What are other side effects people have besides Cardio-respiratory arrest? *

Overdose: 44 people, 77.19%
Poisoning: 25 people, 43.86%
Arteriosclerosis Coronary Artery (thickening and hardening of arteries- coronary artery): 18 people, 31.58%
Drug Dependence: 17 people, 29.82%
Completed Suicide (act of taking one's own life): 3 people, 5.26%
Ventricular Fibrillation (abnormally irregular heart rhythm): 2 people, 3.51%
Oxygen Saturation Decreased: 1 person, 1.75%
Pancreatitis Haemorrhagic (inflammation of pancreas with bleeding): 1 person, 1.75%
Respiratory Distress (difficulty in breathing): 1 person, 1.75%
Atelectasis (partial or complete collapse of the lung): 1 person, 1.75%

What are the existing conditions these people have? *

Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 25 people, 43.86%
High Blood Pressure: 2 people, 3.51%
High Blood Cholesterol: 2 people, 3.51%
Diabetes: 2 people, 3.51%
Sleep Disorder: 1 person, 1.75%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 1.75%

* Approximation only. Some reports may have incomplete information.

Do you take Methylphenidate hydrochloride and have Cardio-respiratory arrest?

- Check whether Cardio-respiratory arrest is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Methylphenidate hydrochloride:

Methylphenidate hydrochloride (6,822 reports)

Browse all side effects of Methylphenidate hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cardio-respiratory arrest:

Cardio-respiratory arrest (1,647 drugs)

Browse all the conditions that are associated with Cardio-respiratory arrest:

Cardio-respiratory arrest (1,767 conditions)

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on methylphenidate hydrochloride (the active ingredients of Methylphenidate hydrochloride) and Methylphenidate hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.